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posits, that reflects “almost exclusively a white, middle 
class, perspective”.7
Second, the options available to women once they have test 
results are, in reality, quite limited. Their capacity to control 
their circumstances may be restricted to a simple decision 
about whether to continue with a pregnancy or not. One 
can imagine ways in which we might expand the available 
choices, for example, by ensuring that whatever diseases 
or conditions a child is born with will be treatable and/or 
manageable by available resources.7
Finally, even if we accept that there is a demand for 
information, particularly in the burgeoning realm of screening 
for genetic conditions, how much people actually understand 
about the conditions for which they may be screened is 
unclear. How well are people able to interpret information 
about genetic status, particularly if that information includes 
complex statements about risk and susceptibility to disease? If 
we are contemplating mass screening for genetic conditions, 
we need also to factor in the possibility that those who 
provide information about screening may not be competent to 
explain the nature of screening to their patients, or to answer 
questions before and after test results are available.8
Conclusion
The principles that guide screening have been well described 
for almost 40 years. For most of this period, ethical debate 
about the interpretation of these principles has focused 
on the extent to which screening programs can prevent 
or reduce the burden of disease.  More recently, some 
screening programs, particularly in prenatal and genetic 
testing, have been justified in terms of their capacity to 
enhance personal autonomy. This paper has suggested that 
neither the preventive nor the autonomy enhancing rationale 
can be taken at face value. In both cases, arguments about 
whether a screening program is, indeed, “good” will need 
to be made on a case by case basis, with careful attention to 
the circumstances and context of the individual program.
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Introduction
Across the world, terms like “inequalities”, “disparities” and 
“inequities” are often used interchangeably in academic and 
policy literatures.1 Even when they are defined, there seems 
little consensus about their meaning or measurement.2,3 
The rationale for this paper is to distinguish “inequity” 
from both “inequality” and “disparity” and to go on to 
highlight how we might measure and monitor the equity 
of healthcare provided to groups or populations. The paper 
is divided into two main sections. The first section focuses 
on the definition, measurement and monitoring of the 
equity of healthcare. The second section uses actual data 
on cervical screening rates in South Australia to highlight 
issues around the inequitable uptake of preventive services. 
Throughout both sections of the paper, we outline some of 
the suggested reasons for inequitable healthcare services 
and suggestions for future research.
Whilst much of the public health research literature on 
equity focuses on equity in health (i.e. in terms of morbidity, 
mortality, and proxies of illness/wellbeing using measures 
like quality adjusted life-years, disability adjusted life-
years, SF36, etc), this paper focuses attention on equity in 
healthcare.
The definition of healthcare used in this paper is fairly wide, 
and includes preventive services (e.g. cancer screening, 
women’s health clinics), treatments (e.g. prescribing), 
acute and chronic services, and services provided by a vast 
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array of medical, allied health and social care professionals. 
It is widely recognised in public health, although not 
uncontentious, that formal healthcare services may have 
a limited impact on the health of populations, and that 
policy and finances should focus on the wider social and 
economic determinants of health. In these terms, healthcare 
(as a social system) should be viewed as one of the social 
determinants of health. Therefore, the equity of healthcare 
should be contextualised by reference to the equity of 
access to quality education, the equity of access to clean, 
safe public spaces, the equity of access to affordable public 
transport, etc. If we were to take a lead from Social Systems 
Theory, 4-7 we would want to explore issues of equity 
in each of the social systems within society (e.g. legal, 
economic, medical, political, environmental, etc) in order, 
firstly to construct a bricolage of inequities and secondly, 
to understand how we can impact on inequities in different 
social systems to have a “joined up” approach to the 
problem.  
Inequity, inequality and disparity – taking the mud from 
the water
The terms “inequality” and “disparity” tend to be used in 
different geographical contexts, with “inequality” being 
preferred in Western Europe, whereas “disparity” tends 
to predominate in the US.2  Nevertheless, the two terms 
are very similar in meaning – essentially they are defined 
by “difference” with no reference to the context, nature or 
direction of the difference or who may be adversely affected 
by the difference. In this way, disparities or inequalities in 
healthcare may simply refer to differences in the use, access, 
availability or quality of healthcare by different groups.  
The central ingredient missing from definitions of inequality 
or disparity is the idea of “social”, “justice” or “fairness”. 
This is where “equity” becomes particularly useful, since it 
focuses research, policy and practice on exploring, attending 
to and monitoring healthcare which is deemed to be “unfair”. 
There may be differences in healthcare use between various 
groups, but is it fair? For example, we may find that older 
people use particular healthcare services more than younger 
people – but that does not necessarily mean that access to 
those services are inequitable (i.e. unfair to younger people). 
It may just be the case that older people are in greater 
need for the specific services. Indeed, it may actually be 
the case that the older people are not in fact receiving high 
enough levels of those services, and therefore, the services 
may be inequitable in the opposite direction. Nevertheless, 
“fairness” or “social justice” is the key area of concern.
Defining, measuring and monitoring the equity of 
healthcare
One of the most important principles of health care systems 
in the developed world is based around the notion of equity, 
whereby healthcare services should be provided solely 
on the basis of clinical need. However, there is a huge 
research literature demonstrating that access to, quality 
of, and outcomes from healthcare are inequitable across 
a number of clinical areas including surgical interventions 
in coronary care,8,9 screening for a variety of cancers,10-15 
and primary care prescribing for coronary heart disease.16-18 
These examples would fulfil Julian Tudor-Hart’s notion of the 
“inverse care law”,19 whereby the groups with the greatest 
levels of need receive the lowest levels of service.
There is much literature around how to define, operationalise 
and measure equity in relation to health care services, 2,3 
20-22 although equity is generally taken to mean “fair” or 
“socially just”. Equity has been generally conceptualised as 
either horizontal equity or vertical equity.  Vertical equity 
works on the principle that individuals or groups that are 
“different” should be treated differently, according to their 
levels of healthcare need. Whilst this is fairly uncontentious, 
it is not straightforward to operationalise and monitor in 
a public health context. Horizontal equity works on the 
principle of equal treatment for individuals or groups with the 
same (or similar) levels of healthcare need. For the example 
of cervical cancer screening, the major determinants of 
“need” for population-based screening would be age and 
sex. Therefore, using the framework of horizontal equity, 
one may expect that the provision, access and uptake of 
cervical cancer screening services would be similar between 
a group of 50-60 year old women in one town and a similar 
group of women in another town. If there were systematic 
differences in uptake of cervical cancer screening services 
(i.e. differences in terms of social class, ethnicity, etc), then 
we could suggest an inequitable uptake.
Equity of healthcare has been divided into three domains: 
equal access to health care for people in equal need; equal 
treatment for people in equal need; and equal outcomes 
for people in equal need.20 Whilst this is a simplification of 
the nature of equity, it is useful in delineating the various 
domains in which inequities may arise. However, implicit in 
these domains of equity are terms which themselves require 
definition. For the purposes of this paper, we briefly mention 
two of these terms – access and need.
In a seminal paper, Aday & Anderson outlined different 
mechanisms for understanding and defining access.23  
They coined the terms “potential access” and “realised 
access” to differentiate between providing the mechanisms 
for people to access services (e.g. culturally appropriate 
information, adequately located services, appropriate staff 
mix, etc) and the actual utilisation of those services. Goddard 
& Smith20 have built on this definition of access, to provide 
the following: “the ability to secure a specified range of 
services, at a specified level of quality, subject to a specified 
maximum level of personal inconvenience and cost, whilst 
in possession of a specified level of information” (nb. bold 
added). This definition begins to make “access” amenable 
to policy makers, since the word “specified” allows them to 
shape access in relation to local circumstances (i.e. allow for 
differences).  
In terms of defining “need”, we can only scratch the surface 
here. There is much literature spanning philosophy, social 
policy, economics and public health, which cover everything 
from basic human needs,24,25 through human rights and 
capabilities, 26-28 through to health needs assessment.29-33  
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For our purposes, a useful way of conceptualising healthcare 
need is the “Taxonomy of Need”, 34,35 which is widely used 
in healthcare needs assessment. This taxonomy has four 
domains of need, each of which represents a different 
dimension of need which can be studied separately. When 
combined, however, Bradshaw states that we can get 
somewhere close to understanding overall need.  The 
first domain is “normative need” which is that defined by 
an “expert”.  This “expert” may be in the form of a local 
GP, school teacher or evidence-based guidelines for the 
treatment of a particular group of people (e.g. risk factors 
for those with diabetes). The second domain is “felt need” 
which is determined by asking people what they feel they 
need (i.e. akin to “wants”). This domain assumes perfect 
and equal information across groups in society about what 
services are available, which is obviously contestable. 36,37  
The third domain is “expressed need” which may also be 
conceptualised as “service utilisation”. This may be measured 
through activity statistics, prescribing data, surgical 
statistics, etc, although not all “felt need” gets turned into 
“expressed need” – there will be groups of people who 
experience unmet need. The fourth domain is “comparative 
need”, which is akin to horizontal equity. Comparative need 
is determined by studying the characteristics of differing 
populations in receipt of differing levels of a service (e.g. 
differing rates of cervical cancer screening). Using the 
example of cervical cancer screening, a comparative 
approach to need would assess the differences in screening 
rates between population A and population B, weighted 
to take account of the relevant risk factors in the patient 
populations. However, it needs to be remembered that this 
approach is purely comparative. Therefore, if population A 
is deemed to be in need in comparison to population B, 
this does not necessarily mean that population B is not in 
need – the screening rates for population B may not be at 
an adequate level. This approach merely attempts to assess 
comparative need (or equity), and makes no judgements 
about the appropriateness of screening rates.
In summary, understanding the equity of healthcare services 
requires us to also understand the related concepts of 
access, need and utilisation of those services. In order to 
fully understand the equity of cervical cancer screening in 
South Australia and respond to any areas of inequity, we 
need to be able to measure and monitor both need for those 
services and access (potential and realised) to the services.
Data on cervical cancer screening in South Australia – an 
inequitable pattern?
The National Cervical Screening Program (NCSP), a 
joint initiative of the Australian and State and Territory 
governments, aims to reduce mortality and deaths from 
cervical cancer, in a cost-effective manner through an 
organised approach to cervical screening. The NCSP has 
particular guidance:  
• Routine screening with Pap smears should be carried out 
every two years for women who have no symptoms or 
history suggestive of cervical pathology. 
• All women who have ever been sexually active should start 
having Pap smears between the ages of 18 and 20 years, 
or one or two years after first having sexual intercourse, 
whichever is later. In some cases, it may be appropriate to 
start screening before 18 years of age. 
• Pap smears may cease at the age of 70 years for women 
who have had two normal Pap smears within the last five 
years. Women over 70 years who have never had a Pap 
smear, or who request a Pap smear, should be screened.
This policy applies to women with no symptoms and normal 
Pap smear results who should be screened every two years. 
38  It is estimated that approximately 90% of cases of cancer 
of the cervix could be prevented if all women in the target 
group were screened biennially.39
Inherent in the national policy is the notion that need for 
screening is a normative need which is determined only by 
sex, age and the woman having ever been sexually active. If 
horizontal equity in cervical screening existed, the realised 
access of participation in the NCSP should be equivalent in 
sub-groups of women within the target population.  
A component of the NCSP is that all Pap smear results are 
recorded on state/territory based cervical cytology registers. 
The registers serve a number of functions including being 
used to remind women and their health care providers 
when women are overdue for Pap smear tests. Less than 
1% of women choose to opt out of having their personal 
details recorded on the SA register. It is therefore possible to 
calculate the biennial participation rate in the program from 
the number of women recorded as having a Pap smear taken 
within a two year period divided by the Australian Bureau 
of Statistics (ABS) Estimated female Resident Population 
averaged for the two year period and corrected by the 
National Health Survey estimated hysterectomy rates for 
each five year age group.40,41 The SA biennial participation 
rate for women aged 20-69 years for 2003-2004 was 62.7%. 
Additionally, data collected by the SA Cancer Registry is 
available to provide information on equity of outcomes for 
population sub-groups of women.
Access to screening by women living in rural areas is an 
issue that SA Cervix Screening has monitored over time. 
Potential access barriers to screening such as limited 
availability of GPs and more specifically, limited availability of 
female GPs has been postulated to reduce potential access 
to Pap smear providers for rural women. In conjunction 
with local health care providers, the NCSP has incorporated 
a variety of mechanisms to improve potential access 
to screening by rural women including funding health 
promotion projects undertaken by rural Women’s Health 
Nurses, arranging for visiting female GPs to conduct clinics 
and, in 2005, two Medicare items (10998 and 10999) were 
introduced which facilitated Pap smears being taken by 
practice nurses on behalf of GPs in regional rural and remote 
areas.42
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Data from the SA cervical cytology register shows that 
the biennial participation rate amongst women residing in 
Metropolitan Health Regions is higher than the rate for rural 
women overall (see Figure 1). This discrepancy has lessened 
over recent years, essentially because the screening rate 
in metropolitan women has fallen over time. When rates of 
participation are examined in more detail, many rural areas 
have participation rates which are higher than the SA rate 
overall, thus it is evident that realised access is variable and 
not necessarily inequitable in many rural areas. Similarly, for 
rural women overall, SA Cancer Registry data for the period 
1994-2003 does not support inequity of outcome for rural 
women with annualised rates of cervical cancer per 100,000 
women of 10.5 for metro women and 9.3 for rural women for 
the period 1994-1998, and respective rates of 9.2 and 8.0 for 
the period 1999-2003.
Data recorded within the cervical cytology register is 
limited to information supplied to the testing laboratory on 
the pathology request form plus results of cytology and 
histopathology tests. Thus, no information on ethnicity is 
recorded and it is not possible to calculate the screening 
participation rates for either Aboriginal or Torres Strait 
Islander (ATSI) women nor for women from various culturally 
and linguistically diverse (CALD) communities.
Using SA Cancer Registry data, the cervical cancer incidence 
rate per 100,000 women for the period 1994-1998 was 
12.3 for ATSI women and 8.8 for non-Aboriginal Australian 
born women. For 1999-2003 these rates were 13.9 and 
7.5 respectively. Data on aboriginality/country of birth was 
missing for 24% of cases and the actual numbers of cases 
in each period are small, thus, it is necessary to exercise 
caution in interpretation of these rates. The increased rate 
for Aboriginal women in the latter period may be a result 
of Aboriginal women newly participating in the program. 
However, the fact that the rate in Aboriginal women is 40% 
higher than in non-Aboriginal women in 1994-1998 and 85% 
higher in 1999-2003 supports inequity of outcomes, thus, SA 
Cervix Screening has a Well Women’s Program which aims to 
increase participation in the screening Program by Aboriginal 
women. The Well Women’s Program focuses on provision of 
culturally appropriate health promotion activity and provision 
of culturally appropriate resources and services for Aboriginal 
women (refer to Sharon Clarke’s article, later in the Bulletin). 
Reporting on the range of strategies targeting unscreened 
and underscreened women, with a particular focus on ATSI 
women, to improve participation in cervical screening is 
also incorporated into the Programs funding source via the 
“Public Health Outcome Funding Agreement (PHOFA) 2004-
2005 to 2008-2009”. 
Data on women from CALD communities is limited as 
previously discussed. However, SA Cancer Registry data 
for the period 1977-2000 demonstrated that Australian-born 
women had an incidence about 9% lower than residents 
born overseas. The difference was particularly pronounced 
for women born in Germany and Eastern Europe with the 
incidence in German-born women in SA being approximately 
twice the rate of Australian-born women. The incidence of 
cervical cancer in overseas-born South Australians was, in 
general, much lower than for their parent populations.43  It 
is postulated that potential access to Pap smear testing is 
affected by cultural norms, with many new migrant women 
not coming from countries with strong preventive health and 
women’s health programs in place and with cultural beliefs 
about, for example, modesty and cancer affecting their 
willingness to participate in the cervical cancer screening 
program. The SA Cervix Screening Program funds a Senior 
Project Officer who works collaboratively and holistically 
with the BreastScreen SA and The Cancer Council SA CALD 
project officers to reduce barriers to potential and realised 
access.  
There are also women in minority groups such as lesbian 
women and women with various disabilities who may face 
potential physical and psychological barriers to cervical 
cancer screening. Although, the realised access for women 
in these groups in terms of their participation in the Program 
is unknown, the NCSP has sought to incorporate measures 
to address perceived potential barriers into the Program. 
Figure 1: SA Biennial Cervix Screening Participation rates: Country vs Metro from 1996 to 2003
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These include specific printed resources for lesbian women 
and women with disabilities and the provision of height 
adjustable beds to clinics which provide Pap smear.
Figure 2 shows the biennial participation rate for 2003-
2004 analysed by socio-economic status (using ABS Socio-
Economic Index for Areas Index of Disadvantage quintiles).(1) 
For all age groups, lower socio-economic status is correlated 
with lower participation rates. This data is consistent with 
SA data for previous years. For the period 1999-2003, SA 
Cancer Registry data indicates that the incidence of cervical 
cancer correspondingly increased as socio-economic status 
declined, ranging from an annualised rate of 6.3 cases per 
100,000 women in the highest quintile to 11.9 in the lowest 
quintile. There are often complex barriers for women in 
low socio-economic areas that prevent them from having 
a Pap smear. These women are often confronted daily with 
immediate and urgent life issues including compounding 
effects of poverty, domestic violence, sole parenting, 
housing issues and mental and chronic illness.  Women in 
low socio-economic areas may need more support to have 
regular Pap smears than women from more affluent areas. 
Research shows that women who don’t have Pap smears 
say they would be more willing to screen if their health 
practitioner told them it was important.
Summary
This paper sets the context for research and policy around 
the equity of healthcare within the broader theoretical 
framework of Social Systems Theory and the social and 
economic determinants of health. In other words, striving for 
a more equitable society means striving for equity within all 
social systems (e.g. legal, medical, economic, political, etc). 
The paper also  outlines the differences between inequality 
and inequity and provides a framework for conceptualising, 
operationalising, measuring and monitoring the equity of 
healthcare. This paper provides data on both the equity of 
cervical cancer and participation in cervical cancer screening 
in South Australia.  From the available data, the paper 
demonstrates higher rates of cervical cancer in ATSI women 
and in women from lower socio-economic groups, in addition 
to lower participation rates in cervical cancer screening for 
women from lower socio-economic groups. Due to data 
limitations, we were not able to undertake multivariate 
analyses and therefore these ecological associations require 
further research.
Notes
(1) Socio-Economic Indexes for Areas 2001 (SEIFA 2001) is a product  in 
which the ABS has developed indexes to allow ranking of regions/
areas, providing a method of determining the level of social and 
economic well-being in that region.  The Index of Disadvantage is 
derived from attributes such as income, educational attainment, 
unemployment, and dwellings without motor vehicles. In particular 
it focuses on low income earners, relatively lower educational 
attainment and high unemployment.  Index of disadvantage scores 
have been grouped into quintiles (highest, high, middle, low, lowest) 
for analysis. The highest quintile represents the highest 20% of 
postcode scores (20% of the population) and is the most advantaged 
areas.  The lowest quintile represents the lowest scores and the 
most disadvantaged areas.
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